tm
Seeing Is Believing
tm
Seeing Is Believing
ATHE is currently covered by 1 analysts with an average price target of $10. This is a potential upside of $5.35 (100.8%) from yesterday's end of day stock price of $4.98.
Alterity Therapeutics Ltd's activity chart (see below) currently has 2 price targets and 3 ratings on display. The stock rating distribution of ATHE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 476 days.
Highest price target for ATHE is $10, Lowest price target is $10, average price target is $10.
Most recent stock forecast was given by from LADENBURG on 16-Jun-2026. First documented stock forecast 03-Aug-2022.
Currently out of the existing stock ratings of ATHE, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2022
$10
$5.18 (107.47%)
$10
1 months 3 days ago
(16-Jun-2026)
1/3 (33.33%)
$5.35 (115.05%)
476
What is ATHE (Alterity Therapeutics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on ATHE (Alterity Therapeutics Ltd) with a proven track record?
Which analyst has the most public recommendations on ATHE (Alterity Therapeutics Ltd)?
Which analyst is the currently most bullish on ATHE (Alterity Therapeutics Ltd)?
Which analyst is the currently most reserved on ATHE (Alterity Therapeutics Ltd)?
